Cargando…
How does NFAT3 regulate the occurrence of cardiac hypertrophy?
Cardiac hypertrophy is initially an adaptive response to physiological and pathological stimuli. Although pathological myocardial hypertrophy is the main cause of morbidity and mortality, our understanding of its mechanism is still weak. NFAT3 (nuclear factor of activated T-cell-3) is a member of th...
Autores principales: | Hui, Wang, Wenhua, Su, Shuojie, Zhang, Lulin, Wang, Panpan, Zhao, Tongtong, Zhang, Xiaoli, Xie, Juhua, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518445/ https://www.ncbi.nlm.nih.gov/pubmed/37753338 http://dx.doi.org/10.1016/j.ijcha.2023.101271 |
Ejemplares similares
-
The function of LncRNA-H19 in cardiac hypertrophy
por: Su, Wenhua, et al.
Publicado: (2021) -
A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021) -
NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020) -
Single-cell and bulk RNA-sequencing analysis to predict the role and clinical value of CD36 in lung squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2023) -
GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2016)